Lupin Limited has informed the Exchange regarding a press release dated Jun 29, 2023, titled "Lupin Announces Achievement of Key Milestone for its Phase 1 Clinical Stage MALT1inhibitor Program.".
Lupin Limited has informed the Exchange regarding a press release dated Jun 29, 2023, titled "Lupin Announces Achievement of Key Milestone for its Phase 1 Clinical Stage MALT1inhibitor Program.".